GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference
GlycoMimetics, Inc. (GLYC) CEO to participate in the Leukemia Panel at the Cowen 44th Annual Health Care Conference. The event will be held on March 4, 2024, at 12:50 p.m. ET in Boston, MA. A live webcast and archived recording will be accessible on the company's website.
02/26/2024 - 07:00 AM
ROCKVILLE, Md. --(BUSINESS WIRE)--
GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that Harout Semerjian, Chief Executive Officer, will participate in the Leukemia Panel at the Cowen 44th Annual Health Care Conference in Boston, MA on Monday, March 4, 2024 at 12:50 p.m. ET.
A live webcast of the panel presentation will be available on the GlycoMimetics website at https://ir.glycomimetics.com/investor-relations . An archived recording will be available for 30 days following the event.
About GlycoMimetics, Inc.
GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, including AML, and for inflammatory diseases. The Company’s science is based on an understanding of the role that carbohydrates play in cell recognition. Its specialized chemistry platform is being deployed to discover small molecule drugs--known as glycomimetics--that alter carbohydrate-mediated recognition in diverse disease states, including cancers and inflammation. As a leader in this science, GlycoMimetics leverages this unique approach to advance its pipeline of wholly-owned drug candidates. The Company’s goal is to develop transformative therapies for diseases with high unmet medical need. GlycoMimetics is headquartered in Rockville, MD in the BioHealth Capital Region. Learn more at www.glycomimetics.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226192834/en/
Investors:
Glycomimetics@argotpartners.com
Source: GlycoMimetics, Inc.
When will the CEO of GlycoMimetics, Inc. participate in the Leukemia Panel at the Cowen 44th Annual Health Care Conference?
The CEO will participate on March 4, 2024, at 12:50 p.m. ET.
Where will the Cowen 44th Annual Health Care Conference take place?
The conference will be held in Boston, MA.
How can I access the live webcast of the panel presentation?
The live webcast will be available on the GlycoMimetics website.
For how long will the archived recording of the event be available?
The archived recording will be available for 30 days following the event.
GLYC Rankings
#251 Ranked by Stock Gains
GLYC Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Rockville
About GLYC
at glycomimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments. glycomimetics is a clinical-stage biotechnology company. we use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. since the company’s inception in 2003, we have developed a robust, diversified product pipeline. we are a public company traded on the nasdaq under the symbol glyc.
